Recursion Pharmaceuticals, Inc. (BX:RXRX) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Robert Hershberg Other companies: Danaher Corporation (Director · Since at least Nov 15, 2026); AtaiBeckley Inc. (Director · Since at least Jun 4, 2026); Hillevax Inc (President and CEO, Director · Since at least Apr 28, 2022); Adaptive Biotechnologies Corporation (Board Member · Since at least Jun 26, 2019); ARS Pharmaceuticals, Inc. (Director · Dec 3, 2020 – Jun 10, 2022 · Past); Fate Therapeutics, Inc. (Director · May 1, 2020 – Jun 6, 2023 · Past); NanoString Technologies Inc (Director · Mar 2, 2015 – Apr 18, 2022 · Past); Dendreon Corp (Sr. VP & Chief Medical Officer · Dec 31, 2005 – Jan 19, 2006 · Past) | Board Member · Since at least Apr 15, 2021 |
| Fred Hassan Other companies: EyePoint, Inc. (Director · Since at least Sep 3, 2024); Cocrystal Pharma, Inc. (Director · Since at least Apr 20, 2023); BridgeBio Pharma, Inc. (Director · Since at least Aug 17, 2021); Precigen, Inc. (Director · Since at least Jun 30, 2016); Prometheus Biosciences Inc (Director · May 14, 2021 – Jun 16, 2023 · Past); Time Warner Inc (Director · Jun 1, 2016 – Jun 14, 2018 · Past); Amgen Inc. (Director · Jul 28, 2015 – May 5, 2020 · Past) | Director · Since Oct 31, 2026 |
| David J Mauro Other companies: Codiak BioSciences Inc (Chief Medical Officer · May 2, 2022 – Jan 24, 2023 · Past); Prelude Therapeutics Incorporated (Chief Medical Officer · Sep 24, 2020 – Oct 5, 2021 · Past); Advaxis Inc (Chief Medical Officer · Oct 20, 2014 – Dec 31, 2015 · Past) | Chief Medical Officer · Jun 1, 2023 – Nov 15, 2024 · Past |
| Elaine Sun Other companies: Dynavax Technologies Corporation (Director · Since at least Dec 10, 2021); Halozyme Therapeutics, Inc. (SVP, Chief Financial Officer · Mar 2, 2020 – Apr 1, 2021 · Past) | Board Member · Since at least Mar 15, 2025 |
| Fred Hassan Other companies: Cocrystal Pharma, Inc. (Director · Since at least Oct 30, 2025); EyePoint, Inc. (Board Member · Since at least Nov 7, 2024) | Chair of the Board · Since at least Nov 2, 2026 |
| R. Martin Marty Chávez Other companies: Alphabet Inc (Google) Class C (Board Member · Since at least Jul 11, 2022); Goldman Sachs Group, Inc. (the) (Executive Vice President - CFO · May 1, 2017 – Feb 7, 2018 · Past) | Director · Apr 15, 2021 – Apr 1, 2024 · Past |
| Terry-Ann Burrell Other companies: Rapport Therapeutics, Inc. (Director · Jun 6, 2024 – Jun 6, 2024 · Past); Beam Therapeutics Inc. (Chief Financial Officer · Feb 5, 2020 – Apr 26, 2024 · Past) | Director · Apr 15, 2021 – Jul 1, 2024 · Past |
| Ben R Taylor Other companies: Tyme Technologies Inc (President, CFO · Jul 27, 2017 – May 7, 2020 · Past) | Chief Financial Officer · Since at least Nov 20, 2024 |
| Chris Gibson Other companies: Pacific Biosciences of California, Inc. (Director · Mar 5, 2026 – Nov 5, 2026 · Past) | Director · Mar 5, 2026 – Nov 5, 2026 · Past |
| Christopher Gibson Other companies: Pacific Biosciences of California, Inc. (Director · Since at least Mar 3, 2026) | Director · Since at least Apr 15, 2021 |
| Dean Li Other companies: Merck & Company, Inc. (Executive VP & President, MRL · Since at least Jan 1, 2021) | Board Member · Since at least Apr 15, 2021 |
| Michael Secora Other companies: Iambic Therapeutics, Inc. (Chief Financial Officer and Chief Corporate Development Officer · Since at least Oct 16, 2026) | Chief Financial Officer · Apr 15, 2021 – Nov 15, 2024 · Past |
| Ben Mabey | Chief Technology Officer · Since at least Nov 12, 2024 |
| Ben Taylor | Chief Financial Officer & President Recursion UK · Since at least May 5, 2025 |
| Blake Borgeson | Board Member · Since at least Apr 15, 2021 |
| David Hallett | Chief Scientific Officer · Since at least Jul 8, 2025 |
| Erica Fox | Chief People and Impact Officer · Since at least Nov 6, 2024 |
| Franziska Michor | Board Member · Since at least Nov 20, 2024 |
| Matt Kinn | Chief Business Officer · Since at least Nov 4, 2026 |
| Najat Khan | CEO and President · Since at least Apr 16, 2024 |
| Namandjé Bumpus | Board Member · Since at least Mar 15, 2025 |
| Nathan Hatfield | Chief Legal Officer & Corporate Secretary · Since at least Nov 4, 2026 |
| Ramona Doyle | Chief Medical Officer · Apr 15, 2021 – May 16, 2022 · Past |
| Ryan Kelly | Chief Communications Officer · Since at least Jul 29, 2026 |
| Shafique Virani | Chief Business Officer · Apr 15, 2021 – Jan 16, 2024 · Past |
| Sid Jain | SVP of Clinical Development & Data Science · Since at least Nov 4, 2026 |
| Tina Marriott | President and COO · Apr 15, 2021 – Nov 15, 2024 · Past |
| Vicki Goodman | Chief Medical Officer · Since at least Oct 26, 2026 |
| Zachary Bogue | Board Member · Since at least Apr 15, 2021 |
| Zavain Dar | Board Member · Since at least Apr 15, 2021 |